Appropriate sensing of ventricular fibrillation after failed shocks in a transvenous cardioverter-defibrillator system.

نویسندگان

  • J R Ellis
  • D T Martin
  • F J Venditti
چکیده

BACKGROUND Reduction in R-wave amplitude immediately after defibrillation shocks in an integrated shock/sense transvenous cardioverter-defibrillator (TCD) lead system has prompted concerns regarding adequate sensing after failed shocks. We therefore studied redetection characteristics for ventricular fibrillation after unsuccessful defibrillation shocks in a TCD system to determine if these observations have clinical relevance. METHODS AND RESULTS Fifty patients with this shock/sense TCD lead system underwent conversion testing of their TCD at several time intervals. There were a total of 142 failed shocks events recorded, including 10, 15, 70, and 47 events at implantation, predischarge, and 2- and 6-month testing, respectively. Initial detection time (IDT) and redetection time (RDT) for ventricular fibrillation were measured from event markers for all unsuccessful defibrillation shocks. To assess the effect of failed shocks on electrogram quality, 54 failed shock episodes were evaluated in 37 of the 50 patients by measuring electrograms during VF before and after shock. Mean RDT for the entire group was 5.3 +/- 3.5 seconds compared with an IDT of 4.5 +/- 3.3 seconds (P = NS). There were no significant differences between IDT and RDT at implantation or any follow-up testing period, despite a significant decline in R-wave amplitude from 8.1 +/- 3.5 to 6.8 +/- 2.8 mV (P < .0001) measured 3 to 6 seconds after shock delivery. Analysis of 8 individuals with any extended RDT (> or = 10 seconds) showed no significant differences in clinical or implantation characteristics when compared with 42 individuals without extended RDT. CONCLUSIONS In this integrated shock/sense TCD lead system, unsuccessful shock delivery has no significant effect on redetection of ventricular fibrillation at device implantation or up to 6 months of follow-up, despite an observed reduction in postshock R-wave amplitude. Therefore, the reported reduction in electrogram quality after a shock is of no practical importance because sensing of ventricular fibrillation does not appear to be compromised in this particular TCD system. Whether this applies to other implantable cardioverter-defibrillator pulse generators and lead systems with different sensing characteristics requires further evaluation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Implantable cardioverter-defibrillator in a patient with dextrocardia situs inversus

Background: Dextrocardia is a congenital anomaly, which may have coexistent coronary artery disease (CAD), arrhythmias and conventional indications for device therapy. However, the implantation of transvenous leads can be technically challenging and the approach needs to be tailored to the patient's individual anatomy. Case presentation: A 54-year-old male with dextrocardia situs inversus and i...

متن کامل

Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing

Introduction The subcutaneous implantable cardioverter-defibrillator system (S-ICD) has been an important alternative to transvenous defibrillators for certain clinical situations, such as when there is a venous access problem or high risk of bacterial endocarditis. This device reliably detects ventricular tachyarrhythmias and effectively delivers shocks. However, oversensing is more common wit...

متن کامل

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation

Introduction The implantable cardioverter-defibrillator (ICD) has reduced mortality in survivors of sudden cardiac arrest and patients at high risk of sudden cardiac death. This benefit comes at the cost of device-related complications, including those related to transvenous leads. The subcutaneous ICD (S-ICD) is an alternative to the conventional transvenous ICD (TV-ICD) system and has no tran...

متن کامل

Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.

BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads. The global EFFORTLESS S-ICD (Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS of the S-ICD) registry is collecting outcomes in 985 patients during a 5-year follow-up. OBJECTIVES The primary goal of the...

متن کامل

Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator

Introduction Implantable cardioverter-defibrillators (ICDs) have been shown to improve survival in patients with ischemic or nonischemic cardiomyopathy when used for primary and secondary prevention settings. The limitations of transvenous ICDs include postimplant adverse events, defibrillator lead failure, and inappropriate shocks for atrial tachyarrhythmias due to fast ventricular response ra...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Circulation

دوره 90 4  شماره 

صفحات  -

تاریخ انتشار 1994